Has Brent Benscoter, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,078 in general payments to Brent Benscoter, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brent Benscoter, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brent Benscoter, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brent Benscoter, MD

Otology & Neurotology · Sacramento, CANPI 1376703454

Payments from drug & device makers

What this record shows

This record is dominated by grants: $5,000 of the $7,078 with a category attached, or 70.6%. Med-el Corporation accounts for 71.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $5,000 and has fallen 93.0% since, to $352 in 2025.

$7,078in general payments, 2019–2025

Across 24 payments — averaging $294.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Med-el Corporation$5K
Oticon Medical, LLC$780
Cochlear Americas$451
Inspire Medical Systems, Inc.$200
Sanofi$120
Regeneron Healthcare Solutions, Inc.$118
plus $364 from 4 others

$26,073in research payments, 2019–2025

Across 1 payment — averaging $26,073 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Hill Dermaceuticals, Inc.$26K

What the payments were for

Grants$5,00071%
Travel & lodging$5888%
Food & beverage$1,49021%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Med-el Corporation	3	$5,046
Oticon Medical, LLC	2	$780
Cochlear Americas	7	$451
Inspire Medical Systems, Inc.	2	$200
Sanofi	1	$120
Regeneron Healthcare Solutions, Inc.	1	$118
Integra Lifesciences Corporation	1	$117
Intersect ENT, Inc.	1	$91
Johnson & Johnson	1	$88
Advanced Bionics, LLC	5	$67

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Mi1250 SYNCHRONY 2 FLEXsoft$5,000
BCI 602 Kit$5,000
ADHEAR Professional Kit$5,000
PONTO BONE ANCHORED HEARING SYSTEM$780
INTEGRA$352
Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$310
Baha$310
OSIA OSI300 IMPLANT$310
DUPIXENT$238
Inspire$125
INTEGRA DERMAL REGENERATION TEMPLATE$117
PRIMATRIX$117

How this compares

$7,078 in reported general payments places this provider in the 70th percentile of 43 otology & neurotology providers in California.

See all otology & neurotology providers in California →

Medicare billing

Part B allowed, 2024

$244,959

Medicare patients

333

Services billed

1,748

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	31	$3,516
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort	63	$3,182
Ofloxacin	49	$1,512
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid	41	$771
Propranolol Hcl ErPropranolol Hcl	13	$386
Ibuprofen	53	$222
Fluticasone Propionate	17	$217
Triamcinolone Acetonide	46	$151
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	44	$151
Cephalexin	31	$133
Ciprofloxacin Hcl	16	$121
Clindamycin Hcl	19	$105
Prednisone	28	$104
Meclizine Hcl	17	$68
Methylprednisolone	14	$64

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Sacramento

Varun VaradarajanSacramento$27K
Kevin McKennanSacramento$3K
Doron SagivSacramento$981
Hilary BrodieSacramento$400
John Vaughanla Jolla$237K
Rodney PerkinsWoodside$125K
Courtney VoelkerLos Angeles$66K
Lloyd MinorStanford$52K
Rick Friedmanla Jolla$34K
Sumit AgrawalStanford$21K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →